Noble, Samara, Bonner, Carissa, Hersch, Jolyn et al. · Patient education and counseling · 2019 · DOI
This study asked university students how they would respond to a close friend who has ME/CFS, comparing situations where the condition was labeled as 'chronic fatigue syndrome' versus unlabeled. When the CFS label was used, students reported they would be more sympathetic, less rejecting, and more supportive of medical treatment for their friend. This suggests that having a recognized disease name might actually help people with ME/CFS receive better social support from their friends.
ME/CFS patients frequently report inadequate social support, which can worsen symptoms and quality of life. This study provides evidence that formally naming the condition as 'chronic fatigue syndrome' may improve how friends perceive and support someone with ME/CFS, offering a potential benefit of disease labeling that is often overlooked in discussions about diagnosis and stigma.
This study does not establish whether these intended responses would translate into actual behavioral support in real-life situations, since it was based on hypothetical scenarios rather than real interactions. It also does not examine how the CFS label affects support from family members, healthcare providers, or employers—only peers. The findings cannot be generalized beyond university-age populations or determine the long-term effects of labeling on support.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.